Alurar rigakafin cutar korona na farko a duniya

Alurar rigakafin cutar korona na farko a duniya

Kanada ta zama ƙasa ta farko da ta ba da izinin yin amfani da maganin rigakafin cutar korona.

Hukumomin Kanada sun fada a ranar Alhamis cewa za a iya ba da allurar rigakafin ta Medicago guda biyu ga manya masu shekaru 18 zuwa 64, amma sun ce akwai karancin bayanai kan allurar rigakafin a cikin mutane 65 da haihuwa.

An yanke shawarar ne kan wani binciken da aka yi na manya 24000 wadanda suka gano maganin yana da tasiri kashi 71% wajen hana Covid-19, kodayake hakan ya kasance kafin mutant omicron ya bayyana. Abubuwan da ke da lahani sun kasance masu sauƙi, ciki har da zazzabi da gajiya.

Medicago tana amfani da tsire-tsire azaman masana'antu masu rai don haɓaka ɓangarorin ƙwayoyin cuta masu kama da sunadarin furotin da ke rufe ƙwayar cuta. Ana cire barbashi daga ganyen tsire-tsire kuma ana tsarkake su. Wani sinadari, wani sinadari mai haɓaka garkuwar jiki da ake kira adjuvant wanda abokin tarayya na Burtaniya GlaxoSmithKline ya yi, an ƙara shi cikin allurar.

Yayin da aka ƙaddamar da yawancin rigakafin COVID-19 a duk duniya, hukumomin kiwon lafiya na duniya suna neman ƙarin ƴan takara da fatan ƙara wadata a duk duniya.

Medicago da ke birnin Quebec yana haɓaka allurar rigakafin shuka daga wasu cututtuka da yawa, kuma maganin COVID-19 na iya taimakawa ƙarin sha'awar wannan sabuwar hanyar masana'antar likitanci.